AJR Custom publishing of AJR articles and ARRS Cat. Course
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pfluger, T.
Right arrow Articles by Hahn, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pfluger, T.
Right arrow Articles by Hahn, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
AJR 2003; 181:1115-1124
© American Roentgen Ray Society


Integrated Imaging Using MRI and 123| Metaiodobenzylguanidine Scintigraphy to Improve Sensitivity and Specificity in the Diagnosis of Pediatric Neuroblastoma

Thomas Pfluger1, Christoph Schmied1, Ute Porn1, Gerda Leinsinger2, Christian Vollmar1, Stefan Dresel1, Irene Schmid3 and Klaus Hahn1

1 Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Ziemssenstr. 1, D-80336 Munich, Germany.
2 Institute for Clinical Radiology, Ludwig-Maximilians-University of Munich, Ziemssenstr. 1, D-80336 Munich, Germany.
3 Department of Pediatrics, Dr. von Haunersches Kinderspital, Ludwig-Maximilians-University of Munich, Lindwurmstr. 4, D-80337 Munich, Germany.

OBJECTIVE. The objectives of this study were to compare MRI and iodine-123 (123I) metaiodobenzylguanidine (MIBG) scintigraphy in the detection of neuroblastoma lesions in pediatric patients and to assess the additional value of combined imaging.

MATERIALS AND METHODS. Fifty MRI and 50 123I MIBG examinations (mean interval, 6.4 days) were analyzed retrospectively with regard to suspected or proven neuroblastoma lesions (n = 193) in 28 patients. MRI and MIBG scans were reviewed by two independent observers each. Separate and combined analyses of MRI and MIBG scintigraphy were compared with clinical and histologic findings.

RESULTS. With regard to the diagnosis of neuroblastoma lesion, MIBG scintigraphy, MRI, and combined analysis showed a sensitivity of 69%, 86%, and 99% and a specificity of 85%, 77%, and 95%, respectively. On MRI, 15 false-positive findings were recorded: posttherapeutic reactive changes (n = 10), benign adrenal tumors (n = 3), and enlarged lymph nodes (n = 2). On MIBG scintigraphy, 10 false-positive findings occurred: ganglioneuromas (n = 2), benign liver tumors (n = 2), and physiologic uptake (n = 6). Thirteen neuroblastoma metastases and two residual masses under treatment with chemotherapy were judged to be false-negative findings on MRI. Two primary or residual neuroblastomas and one orbital metastasis were misinterpreted as Wilms' tumor, reactive changes after surgery, and rhabdomyosarcoma on MRI. Thirty-two bone metastases, six other neuroblastoma metastases, and one adrenal neuroblastoma showed no MIBG uptake. On combined imaging, one false-negative (bone metastasis) and three false-positive (two ganglioneuromas and one pheochromocytoma) findings remained.

CONCLUSION. In the assessment of neuroblastoma lesions in pediatric patients, MRI showed a higher sensitivity and MIBG scintigraphy a higher specificity. However, integrated imaging showed an increase in both sensitivity and specificity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
JNMHome page
C. Franzius, K. Hermann, M. Weckesser, K. Kopka, K. U. Juergens, J. Vormoor, and O. Schober
Whole-Body PET/CT with 11C-Meta-Hydroxyephedrine in Tumors of the Sympathetic Nervous System: Feasibility Study and Comparison with 123I-MIBG SPECT/CT
J. Nucl. Med., October 1, 2006; 47(10): 1635 - 1642.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
W H van Houtum, E P M Corssmit, P B Douwes Dekker, J C Jansen, A G L van der Mey, A H J T Brocker-Vriends, P E M Taschner, M Losekoot, M Frolich, M P M Stokkel, et al.
Increased prevalence of catecholamine excess and phaeochromocytomas in a well-defined Dutch population with SDHD-linked head and neck paragangliomas
Eur. J. Endocrinol., January 1, 2005; 152(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
K. M. Elsayes, G. Mukundan, V. R. Narra, J. S. Lewis Jr, A. Shirkhoda, A. Farooki, and J. J. Brown
Adrenal Masses: MR Imaging Features with Pathologic Correlation
RadioGraphics, October 1, 2004; 24(suppl_1): S73 - S86.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
B. H. Kushner
Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies
J. Nucl. Med., July 1, 2004; 45(7): 1172 - 1188.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Roentgen Ray Society.